|
Online Database of Chemicals from Around the World | Search | Submit | Advertise | |
Home >> Chemical Listing >> Colistimethate Sodium>> Market Analysis Reports |
Market Analysis Reports of Colistimethate Sodium |
|
EC Number: 232-516-9 Colistimethate sodium Chemical Report & Database ... sector. The Colistimethate sodium World Consumption Report & Database definitions: Name: Colistimethate sodium: Colistimethate sodium Chemical Registry ... Cystic Fibrosis Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update Cystic Fibrosis Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update SUMMARY Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Cystic Fibrosis - Drugs In Development, 2022, provides ... Resistant Pseudomonas aeruginosa Infections - Pipeline Review, H2 2020 Resistant Pseudomonas aeruginosa Infections - Pipeline Review, H2 2020 SUMMARY Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Resistant Pseudomonas aeruginosa Infections - Pipeline Review, H2 2020, provides an overview ... Resistant Pseudomonas aeruginosa Infections - Pipeline Review, H1 2020 Resistant Pseudomonas aeruginosa Infections - Pipeline Review, H1 2020 SUMMARY Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Resistant Pseudomonas aeruginosa Infections - Pipeline Review, H1 2020, provides an overview ... Chronic Pulmonary Infections - Pipeline Insight, 2021 ... SNG-001 ION-827359 MEDI3506 Colistimethate sodium inhaled CHF6001 Resistant Pseudomonas aeruginosa Infections (Infectious Disease) - Drugs In Development, 2021 Resistant Pseudomonas aeruginosa Infections (Infectious Disease) - Drugs In Development, 2021 SUMMARY Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Resistant Pseudomonas aeruginosa Infections - Drugs In Development, ... |